Flintbek, Germany

Bernd Wilhelm Mueller

USPTO Granted Patents = 4 



Average Co-Inventor Count = 2.7

ph-index = 1


Company Filing History:


Years Active: 2010-2022

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Bernd Wilhelm Mueller: Innovator in Pharmaceutical Compositions

Introduction

Bernd Wilhelm Mueller is a notable inventor based in Flintbek, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of controlled release compositions. With a total of 4 patents to his name, his work focuses on improving treatment methods for various disorders.

Latest Patents

One of his latest patents involves controlled release pharmaceutical compositions comprising fumaric acid esters. This invention is designed to treat conditions such as psoriasis and other hyperproliferative, inflammatory, or autoimmune disorders. The compositions aim to release the fumaric acid ester in a controlled manner, thereby avoiding local high concentrations of the active substance in the gastrointestinal tract upon oral administration. This innovation helps to reduce gastrointestinal-related side effects, enhancing patient comfort and treatment efficacy.

Career Highlights

Throughout his career, Bernd has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Biogen Swiss Manufacturing GmbH and Boehringer Ingelheim International GmbH. His experience in these organizations has contributed to his expertise in developing innovative pharmaceutical solutions.

Collaborations

Bernd has collaborated with several professionals in his field, including Henrik Nilsson and Hartwig Andreas Steckel. These collaborations have likely enriched his research and development efforts, leading to advancements in pharmaceutical compositions.

Conclusion

In summary, Bernd Wilhelm Mueller is a distinguished inventor whose work in controlled release pharmaceutical compositions has the potential to significantly impact the treatment of various disorders. His innovative approach and collaborations with industry leaders underscore his commitment to advancing pharmaceutical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…